Understanding Venous Thromboembolism (VTE) Prophylaxis in Pediatric Trauma Patients: A Midwest Pediatric Surgical Consortium Research Project (MWPSC).
M
Matthew Landman, MD
Primary Investigator
Overview
The purpose of the study is to demonstrate the safety and effectiveness of a chemical prophylaxis to reduce the incidence of Venous Thromboembolism (VTE) in high risk pediatric trauma patients. This study will help understand which pediatric trauma patients would benefit from VTE prophylaxis by validating screening criteria.
Description
This study will be a two part study. The first part is an observational study for data collection of pediatric trauma patients admitted to participating centers for two years. All pediatric trauma patients who present at participating institutions will be screened to determine whether they are at low risk or high risk for developing VTE. No procedures will be performed for research purposes only, and all data collected will be from standard of care procedures.
In the second part of the study patients participate in a 30 day follow up telephone call or email to determine if there were any delayed findings of a VTE.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
venous thromboembolism, VTE
-
Age: - 17 Years
-
Gender: All
Inclusion Criteria:
- Pediatric trauma patients between birth and 17.5 years of age who meet high risk criteria
Exclusion Criteria:
- Low or no risk patients
Updated on
03 May 2024.
Study ID: 2006004629, SURG-MPSC-VTE
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
